Kerri A. Schoedel

Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians

Kerri A. Schoedel, Ewa Hoffmann, Yushu Rao et al. · Pharmacogenetics · 2004 · 316 citations

Life Sciences, Genetics, Pharmacology +16

Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial

Kerri A. Schoedel, Isabella Szeto, Beatrice Setnik et al. · Epilepsy & Behavior · 2018 · 166 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

A randomized, double‐blind, placebo‐controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use

Kerri A. Schoedel, Nancy Chen, Annie Hilliard et al. · Human Psychopharmacology Clinical and Experimental · 2011 · 86 citations

Medicine, Pharmacology, Pharmacotherapy +17

Do Formulation Differences Alter Abuse Liability of Methylphenidate?

Dolly A. Parasrampuria, Kerri A. Schoedel, Reinhard Schuller et al. · Journal of Clinical Psychopharmacology · 2007 · 72 citations

Medicine, Pharmacokinetics, Pharmacology +14

Down-Regulation of Hepatic Nicotine Metabolism and a CYP2A6-Like Enzyme in African Green Monkeys after Long-Term Nicotine Administration

Kerri A. Schoedel, Edward M. Sellers, Roberta M. Palmour et al. · Molecular Pharmacology · 2003 · 65 citations

Medicine, Pharmacology, Toxicology +15